• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

New Disease and Therapy Review on Urinary Incontinence Features Chapters on Diagnosis, Dosing and Treatment Costs and Treatment

Posted on: Wednesday, 16 May 2007, 15:00 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c57010) has announced the addition of Disease and Therapy Review: Urinary Incontinence to their offering.

The Urinary Incontinence Disease and Therapy Review provides an overview of the disease and its subtypes, with prevalence numbers and percentages for major countries worldwide, information on diagnosis and staging, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the incontinence-related care market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by a senior market research team. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Langes Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

Content Outline:

I. OVERVIEW Total Incontinence Stress Incontinence Urge Incontinence/Overactive Bladder Overflow Incontinence Mixed Incontinence Transient Incontinence

II. INCIDENCE AND PREVALENCE Prevalence Table: (US, Canada, UK, Italy, Spain, Japan, Sweden)

III. DIAGNOSIS Symptoms and Signs Laboratory Findings Special Tests

IV. TREATMENT Total Incontinence Stress Incontinence Urge Incontinence/Overactive Bladder Overflow Incontinence

V. DOSING AND TREATMENT COSTS Table: Dosing and Costs for Commonly Used Pharmacologic Agents

VI. MARKET SIZE

VII. COMMENTS

VIII.REFERENCES/RESOURCES

For more information visit http://www.researchandmarkets.com/reports/c57010.

Source: Business Wire

More News in this Category